| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.3 | Approve Allocation of Income and Dividends | For |
| O.4 | Approve Scrip Dividend Program | For |
| O.5 | Approve Auditors' Special Report on Related-Party Transactions | For |
| O.6 | Advisory Vote on Compensation of Henri Proglio, Chairman and CEO | Abstain |
| O.7 | Authorise Share Repurchase | Oppose |
| E.8 | Authorize Issuance of Equity or Equity-Linked Securities with Pre-emptive Rights up to Aggregate Nominal Amount of EUR 45 Million | For |
| E.9 | Authorize Issuance of Equity or Equity-Linked Securities without Pre-emptive Rights up to Aggregate Nominal Amount of EUR 45 Million | For |
| E.10 | Approve Issuance of Equity or Equity-Linked Securities for up to 20 Percent of Issued Capital Per Year for Private Placements, up to Aggregate Nominal Amount of EUR 45 Million | Oppose |
| E.11 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Oppose |
| E.12 | Authorize Capitalization of Reserves of Up to EUR 1 Billion for Bonus Issue or Increase in Par Value | For |
| E.13 | Authorize Capital Increase of Up to EUR 45 Million for Future Exchange Offers | Oppose |
| E.14 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | For |
| E.15 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | For |
| E.16 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares | Oppose |
| E.17 | Amend Article 10 of Bylaws Re: Shareholding Disclosure Thresholds | For |
| O.18 | Authorize Filing of Required Documents/Other Formalities | For |
